Digestive Diseases News
Spring/Summer 2008

NIDDK News

NIDDK Welcomes Four New Advisory Council Members

Pictured with NIDDK Director Griffin P. Rodgers, M.D., M.A.C.P. (center), are
(from left) Nancy C. Andrews, M.D., Ph.D.; James P. Schlicht, M.P.A.; James W. Freston, M.D., Ph.D.; and David M. Altshuler, M.D., Ph.D. Photo credit: Michael Spencer, NIH. U.S. Department of Health and Human Services Secretary Michael O. Leavitt appointed four new members to the Advisory Council of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The Advisory Council guides the NIDDK’s discussion of broad science policy issues and provides second-level review of funding requests. The new members, who will serve 4-year terms, are

David M. Altshuler, M.D., Ph.D., professor of genetics and medicine at Harvard Medical School, member of the Diabetes Unit and Department of Molecular Biology at Massachusetts General Hospital, and director of the Program in Medical and Population Genetics at the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research in Boston. Altshuler serves on the Diabetes, Endocrinology, and Metabolic Diseases Subcommittee.

Nancy C. Andrews, M.D., Ph.D., dean and vice chancellor of Academic Affairs at Duke University School of Medicine in Durham, NC. She is the only woman to lead one of the nation’s top 10 medical schools and is an internationally renowned researcher in pediatric hematology and oncology. Andrews serves on the Kidney, Urologic, and Hematologic Diseases Subcommittee.

James W. Freston, M.D., Ph.D., the Boehringer Ingelheim Chair of Clinical Pharmacology and professor emeritus at the University of Connecticut School of Medicine at Farmington. Appointed to the NIDDK Advisory Council last year for a 1-year term, Freston has been reappointed this year for a 4-year term. He continues to serve on the Digestive Diseases and Nutrition Subcommittee.

James P. Schlicht, M.P.A., executive vice president and chief government affairs and advocacy officer at the American Diabetes Association (ADA). He is directly responsible for management of all advocacy and government affairs functions and the formulation, adoption, strategic development, and implementation of all ADA public policy positions. Schlicht serves on the Diabetes, Endocrinology, and Metabolic Diseases Subcommittee.

[Top]

NIH Publication No. 08–4552
July 2008